BG106728A - Chemical methods and intermediate compounds - Google Patents

Chemical methods and intermediate compounds

Info

Publication number
BG106728A
BG106728A BG106728A BG10672802A BG106728A BG 106728 A BG106728 A BG 106728A BG 106728 A BG106728 A BG 106728A BG 10672802 A BG10672802 A BG 10672802A BG 106728 A BG106728 A BG 106728A
Authority
BG
Bulgaria
Prior art keywords
chemical methods
preparation
intermediate compounds
intermediates
relates
Prior art date
Application number
BG106728A
Other languages
Bulgarian (bg)
English (en)
Inventor
Michael Gravestock
Kenneth Warren
David Ennis
Angela CURRIE
Debra Ainge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BG106728A publication Critical patent/BG106728A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
BG106728A 1999-12-03 2002-05-20 Chemical methods and intermediate compounds BG106728A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9928499.4A GB9928499D0 (en) 1999-12-03 1999-12-03 Chemical processes and intermediates
PCT/GB2000/004527 WO2001040236A2 (en) 1999-12-03 2000-11-28 Phosphorylation of terminal primary alcohol groups

Publications (1)

Publication Number Publication Date
BG106728A true BG106728A (en) 2003-02-28

Family

ID=10865576

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106728A BG106728A (en) 1999-12-03 2002-05-20 Chemical methods and intermediate compounds

Country Status (22)

Country Link
EP (1) EP1237895A2 (cs)
JP (1) JP2003515539A (cs)
KR (1) KR20020058072A (cs)
CN (1) CN1433421A (cs)
AR (1) AR026700A1 (cs)
AU (1) AU762241B2 (cs)
BG (1) BG106728A (cs)
BR (1) BR0016087A (cs)
CA (1) CA2395052A1 (cs)
CO (1) CO5271712A1 (cs)
CZ (1) CZ20021912A3 (cs)
EE (1) EE200200282A (cs)
GB (1) GB9928499D0 (cs)
HU (1) HUP0204052A2 (cs)
IL (1) IL149641A0 (cs)
IS (1) IS6401A (cs)
MX (1) MXPA02005396A (cs)
NO (1) NO20022605L (cs)
PL (1) PL364762A1 (cs)
SK (1) SK7862002A3 (cs)
WO (1) WO2001040236A2 (cs)
ZA (1) ZA200203876B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
GB0113297D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
AU2002329393B2 (en) 2001-09-11 2008-06-12 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents
JP2005512975A (ja) 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
IL163688A0 (en) 2002-02-28 2005-12-18 Astrazeneca Ab 3-Cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and theiruse as antibacterial agents
RU2004129278A (ru) 2002-02-28 2005-06-10 Астразенека Аб (Se) Химические соединения
ES2258234T3 (es) 2002-08-12 2006-08-16 PHARMACIA & UPJOHN COMPANY LLC N-aril-2-oxazolidinonas y sus derivados.
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US7141570B2 (en) 2002-11-21 2006-11-28 Pharmacia & Upjohn Company N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
DK1656370T3 (da) 2003-06-03 2012-11-26 Rib X Pharmaceuticals Inc Heterocykliske biarylforbindelser og fremgangsmåder til fremstilling og anvendelse af samme
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
EP1713785A1 (en) 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
DE602006019870D1 (de) 2005-06-08 2011-03-10 Rib X Pharmaceuticals Inc Verfahren zur synthese von triazolen
JP5259600B2 (ja) 2006-09-25 2013-08-07 ウォックハート リサーチ センター 置換ピペリジノフェニルオキサゾリジノン
WO2014014845A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064417A2 (en) * 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CN1433421A (zh) 2003-07-30
WO2001040236A2 (en) 2001-06-07
IS6401A (is) 2002-05-28
NO20022605L (no) 2002-06-26
BR0016087A (pt) 2002-08-06
MXPA02005396A (es) 2002-11-29
AR026700A1 (es) 2003-02-26
WO2001040236A3 (en) 2002-05-10
PL364762A1 (en) 2004-12-13
HUP0204052A2 (hu) 2003-03-28
AU762241B2 (en) 2003-06-19
AU1715601A (en) 2001-06-12
EP1237895A2 (en) 2002-09-11
IL149641A0 (en) 2002-11-10
KR20020058072A (ko) 2002-07-12
CO5271712A1 (es) 2003-04-30
ZA200203876B (en) 2003-08-15
GB9928499D0 (en) 2000-02-02
JP2003515539A (ja) 2003-05-07
NO20022605D0 (no) 2002-05-31
CA2395052A1 (en) 2001-06-07
SK7862002A3 (en) 2003-02-04
EE200200282A (et) 2003-06-16
CZ20021912A3 (cs) 2002-08-14

Similar Documents

Publication Publication Date Title
BG106728A (en) Chemical methods and intermediate compounds
BG103485A (en) Ketobanzamides as calpain inhibitors
EP0776327A4 (en) NEW MULTIMERIZATION AGENTS
AU698620B2 (en) Hydrophilated dental impression compounds
MX9702865A (es) Agentes estrogenicos.
WO2003016282A3 (en) Substituted 1h-dihydropyrazoles, their preparation and use
BR0109922A (pt) Compostos quìmicos
DE60112609D1 (en) Pyrazolopyridine
MXPA02012271A (es) Nuevos compuestos que poseen actividad antibacteriana, antifungal o antitumor.
EA200300580A1 (ru) Соединения лактама
DE69739853D1 (de) Synthetische rapamycinderivate als multimerisierende wirkstoffe für chimere proteine mit von immunophilin abgeleiteten domänen
BG106340A (en) Substituted oxoazaheterocyclyl compounds
MXPA02011370A (es) Iminoazinas substituidas.
SE9904108D0 (sv) Nya föreningar
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
BR9709326A (pt) Miméticos g-csfnão peptídios
MXPA01008347A (es) Compuestos quimicos.
PL373377A1 (en) Furancarboxamides
TWI319316B (en) Aminoalcohol derivatives and pharmaceutical compositions containing the same
MXPA02012426A (es) Compuestos nuevos.
WO2003024400A3 (en) Process for the preparation of 1,5-diarylpyrazoles
PL373468A1 (en) Oxathiincarboxamides
SE9904128D0 (sv) Novel compounds
MXPA04005151A (es) Compuestos terapeuticos.
WO2002046152A3 (de) Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben